Medy-Tox Revenue

In the year 2024, Medy-Tox had annual revenue of 228.62B KRW with 3.39% growth. Medy-Tox had revenue of 55.18B in the quarter ending December 31, 2024, a decrease of -18.86%.

Revenue

228.62B

Revenue Growth

+3.39%

P/S Ratio

4.74

Revenue / Employee

317.09M

Employees

721

Market Cap

1,082.86B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	228.62B	7.50B	3.39%
Dec 31, 2023	221.12B	26.02B	13.34%
Dec 31, 2022	195.10B	10.23B	5.53%
Dec 31, 2021	184.87B	44.04B	31.27%
Dec 31, 2020	140.83B	-65.07B	-31.60%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	68.13B
Peptron	3.15B
LigaChem Biosciences	125.90B

Revenue Rankings